Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on American Well's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into American Well's regulatory disclosures and financial reporting.
Phyllis Gotlib, President, International of American Well Corp (AMWL), reported a non-discretionary sale of 4,781 shares of Class A common stock on 09/02/2025 at $6.7815 per share to satisfy tax withholding from restricted stock units that vested on 09/01/2025. After the transaction she beneficially owns 132,110 shares directly; an additional 114,250 shares are reported indirectly through her husband. The sale was an automatic "sell-to-cover" and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Paul Francis McNeice, Chief Accounting Officer and director of American Well Corporation (AMWL), reported a single transaction on Form 4. On 09/02/2025 he sold 113 shares of Class A common stock at $6.7815 per share, and following the sale he beneficially owns 3,892 shares directly. The filing states the shares were sold to pay the tax liability from restricted stock units that vested and settled on 09/01/2025, executed as an automatic "sell to cover" and not a discretionary trade by the reporting person. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
American Well Corporation (AMWL) filed a Form 144 disclosing a proposed sale of 26,500 Class A common shares through Morgan Stanley on the NYSE with an aggregate market value of $180,661.10. The filing lists total shares outstanding as 14,162,309 and shows the approximate date of sale as 09/03/2025.
The securities were acquired on 09/03/2025 via vesting of a restricted stock unit grant; the filer reports acquisition of 55,211 shares through that grant and indicates no securities sold in the past three months. The filing contains the standard Rule 144 attestation language and a signature block remarking criminal penalties for misstatement.
American Well Corporation (AMWL) Form 144 notifies the market of a proposed sale under Rule 144 of 4,781 Class A common shares with an aggregate market value of $32,422.35, expected to occur on 09/02/2025 on the NYSE. The shares were acquired through the vesting of restricted stock units on 09/01/2025. The filing lists total outstanding Class A shares of 14,162,309 and shows prior sales by the same person on 06/02/2025 (4,782 shares, $31,628.15) and 07/01/2025 (4,958 shares, $42,773.16).
Deborah C. Jackson, a director of American Well Corporation (AMWL), reported a sale of 4,531 shares of Class A common stock on 08/19/2025 at a price of $7.1027 per share. The Form 4 states the sale was executed under a Rule 10b5-1 trading plan adopted May 20, 2025, and that the proceeds were used to pay the tax liability from restricted stock units that vested and settled on June 10, 2025. Following the reported transaction, the filing shows 48,194 shares held directly and 612 shares held indirectly by spouse. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Jackson on 08/21/2025.
Form 144 notice from American Well Corporation (AMWL) shows a proposed sale of 13,593 common shares, with an aggregate market value of $98,549.25, to be sold approximately on 08/19/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The shares were acquired as restricted stock units from the issuer on 06/18/2025 and the acquisition/payment date is listed as 06/18/2025. The filer reports no securities sold during the past three months. The form includes the standard representation that the selling person is not aware of any undisclosed material adverse information and references Rule 144 and Rule 10b5-1 considerations.
Roy Schoenberg, Executive Vice Chairman and Director of American Well Corporation (AMWL), was granted 25,000 restricted stock units (RSUs) on 08/13/2025. The RSUs vest in equal installments over three years from the grant date, with portions vesting on each of the first, second and third anniversaries. After giving effect to the reported grant and prior holdings (and adjusted for a 1-for-20 reverse stock split that took effect July 10, 2024), the reporting person beneficially owned 133,302 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Schoenberg on 08/14/2025.
Ido Schoenberg, Chairman and co-CEO of American Well Corp (AMWL), received a grant of 50,000 restricted stock units (RSUs) on 08/13/2025. The RSUs vest in equal installments over three years, with vesting on each of the first, second and third anniversaries of the grant date. After the reported transaction, the filing shows 114,250 shares of Class A common stock beneficially owned directly and an additional 136,891 shares of Class A common stock beneficially owned indirectly through his wife.
Selected financials (June 30, 2025)
Q2 revenue $70,898; three‑month net loss $19,531 (net loss attributable to American Well $19,696; EPS $(1.24)). Six months revenue $137,731; net loss $37,887 (attributable $38,400).
Balance sheet: cash and cash equivalents $219,072; total assets $388,656; total liabilities $94,083; total stockholders' equity $294,573; accumulated deficit $(2,004,326). Deferred revenue $43,259; transaction price allocated to remaining performance obligations $84,725 (71% expected in the 12 months ending June 30, 2026).
- Revenue mix: platform subscription $40,460; visits $22,752; other $7,686 (Q2).
- Divestiture: sale of APC business closed Jan 8, 2025; net proceeds reported $20,400 and a gain of $10,713 recognized in H1 2025.